The potential of PBPK modeling in answering key questions around these drugs.
Masoud Jamei, PhD
Advertisement
Senior Vice President, Research and Development, Certara
Articles by Masoud Jamei, PhD
Advertisement
Latest Updated Articles
Accelerating the Progress of Kinase Inhibitors in OncologyPublished: May 14th 2024 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Future-Proofing Clinical Trial Supply Chains Against Tariff Risks
2
Eli Lilly’s Orforglipron Shows Superior Efficacy Across Multiple Phase III Trials in Type 2 Diabetes
3
Reframing the IND: From Tactical Requirement to Strategic Opportunity
4
Labels That Withstand Liquid Nitrogen
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
